Evaluation of the AO Pediatric Classification for Long Bones Fractures Like a Guide for Treatment and Prognosis (AO-PC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00533130|
Recruitment Status : Unknown
Verified September 2007 by Hospital Cruz Roja Mexicana.
Recruitment status was: Recruiting
First Posted : September 21, 2007
Last Update Posted : September 21, 2007
- Is the AO Pediatric classification for long bones fractures reproductible?
- Is the AO Pediatric Classification for long bones fractures a treatment guide?
- The AO pediatric Classification for long bones fractures could be a prognosis factor?
|Condition or disease||Intervention/treatment|
|Fractures Children||Procedure: clinical evaluation Procedure: observational study|
- To determinate the efectivity of the AO pediatric classification for long bones fractures.
- To evaluate the functionality of the AO pediatric classification for long bones fractures.
- To analyze if the AO pediatric classification for long bones fractures is a prognosis factor
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Observational Model:||Defined Population|
|Official Title:||Phase 2/3 Eficacy Study of the AO Pediatric Classification in Treatment and Prognosis of Long Bones Fractures|
|Study Start Date :||August 2007|
|Estimated Study Completion Date :||July 2008|
Pediatric patients under 16 years old with long bones fractures
Procedure: clinical evaluation
analyze the x ray from each patient and evaluate the treatment y development of bone healing.
Other Name: AO classification
Procedure: observational study
evaluate the walk patron, bone healing and range of motion at 1,3,6,12 months
Other Name: AO clasification
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00533130
|Contact: Jorge D Tejada-Hoyos, M.D.||+52 55 53951111 ext email@example.com|
|Contact: Myriam L Hernandez-Rojas, M.D.||+52 55 firstname.lastname@example.org|
|Hospital Cruz Roja Mexicana, Delegacion Distrito Federal||Recruiting|
|Mexico City, Federal District, Mexico, 11510|
|Principal Investigator: Jorge D Tejada-Hoyos, Resident|
|Sub-Investigator: Carlos Torres-Castro, Resident|
|Sub-Investigator: Eduardo A Caballero-Quirarte, MD Adscrit|
|Sub-Investigator: Marcos R Muciño-Maldonado, MD Adscrit|
|Sub-Investigator: Boris Ortuño-Numbela, MD Adscrit|
|Sub-Investigator: Jesus E Rodriguez-Olguin, MD Adscrit|
|Sub-Investigator: Jose L Rosas-Cadena, MD Adscrit|
|Sub-Investigator: Jose Villaroel, MD Adscrit|
|Sub-Investigator: Humberto L Vives-Aceves, MD Adscit|
|Sub-Investigator: Alejandro Bello-González, TyO Chief|
|Principal Investigator:||Jorge D Tejada-Hoyos, M.D.||orthopaedic resident|